Origins of breast cancer subtypes and therapeutic implications.
about
Induction of apoptosis in human breast cancer cells via caspase pathway by vernodalin isolated from Centratherum anthelminticum (L.) seedsFPA-FTIR Microspectroscopy for Monitoring Chemotherapy Efficacy in Triple-Negative Breast Cancer.BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network.Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor developmentGnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.Late age at first full term birth is strongly associated with lobular breast cancer.Variants of estrogen-related genes and breast cancer risk in European and African American women.Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cellsSlug contributes to cancer progression by direct regulation of ERα signaling pathwayHES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.High tumor budding stratifies breast cancer with metastatic properties.Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated PathwayOverexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control StudyIdentification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis.CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitroThe sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis.Reproductive factors, age at maximum height, and risk of three histologic types of breast cancerHedgehog signalling in breast cancer.Glycerophosphoglycerol, Beta-alanine, and pantothenic Acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines.Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae SpicesTriple-negative breast cancer: present challenges and new perspectives.Breast cancer stem cells and their role in resistance to endocrine therapy.Subtype-Specific Radiation Response and Therapeutic Effect of FAS Death Receptor Modulation in Human Breast Cancer.Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular CarcinomaTranscription factors link mouse WAP-T mammary tumors with human breast cancer.Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients.The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancer.Do 'basal-like' breast cancers really exist?
P2860
Q28486277-2574E1F4-CA7D-4439-978F-F691C74106D6Q30369230-8C9C30EF-735A-4DD7-9375-93C8A9767277Q30497664-1169FBFD-380A-46C8-96E7-925BEAC63CA7Q31014656-360CAADC-531A-4153-B0E3-50F8CC33D975Q33416006-47756E10-3C1C-4077-837A-7306E44B09ADQ33479152-9788C806-DC48-4D1C-90E3-5A7A2ACD0D1DQ33575459-710E3BF2-5570-49F7-8BBB-8DA7C19C62A8Q33620053-68F896D0-45FF-48F1-9C7C-E017E905593CQ34048129-0C794B0E-B04A-4D8A-BD97-0E28E8882463Q34066386-5F806F4A-D4E0-4F66-9D4A-A9B598501396Q34142543-09049DC4-8E87-4575-B05F-7F61ECDAB2D2Q34179808-F65129A8-C923-4302-83FB-2461E8BEF645Q34426481-E079367D-E189-40C3-ADBB-C434ED4662AAQ34564798-A993458F-2EA1-4D9A-915F-260321C57B64Q35167068-A31423D4-6F78-4D1E-B41B-350A424D3FFBQ35168129-771C9449-FCD3-4FD5-9B99-5F7B613336FCQ35181168-EE81F149-6A73-4466-A67B-0C62E4702B53Q35203546-34D06873-DC1D-4D8B-97BB-75BF1AD67D6AQ35558070-2891F0A9-6663-424C-8673-FA695A67F65DQ35684577-4505DD11-5C56-4963-B1BA-70F8115AA04FQ35879517-6634CFB8-8F0F-4825-AE33-1376D039A50EQ36057732-51717A37-2D1C-4295-959F-E7E3EFCF04CDQ36230381-326DA37E-1F1F-4652-84B9-7EFA6DB51E54Q36338782-C8CC4AF2-0957-4D46-8789-57EB44148BFAQ36385360-15DEF38C-6D76-4938-8506-A43BDAA83B3DQ36651350-B0DD9CDA-B25D-4D65-908D-AA11837299FAQ37074121-15A4330D-0930-4BED-8770-959880E95A21Q37120162-9BC334F6-5247-420A-81EC-6BD821F9DBA5Q37214195-EB3C2860-5D87-438A-A97C-C37812AE0217Q37608829-523676F2-5383-4147-982D-B4F196E946D7Q37678826-094EB77D-F7BF-4EF7-9EAD-F83C57B8CBA1Q37691006-FF96104D-E0F5-4DAD-8415-B8AB3ADC4C60Q37764168-9F08253A-E997-444E-B0C8-8FFDA3AA7241Q37901429-95D5C1AF-7124-48A8-B4DC-663652D049AEQ38700756-8799CBB5-F27D-473E-81B5-306CA6FB37B8Q38828541-B14E7BBB-ACBC-4227-BC16-2CCBDEEA8924Q39242906-86FC6A45-37E3-440E-9816-2577DB534156Q40216038-1F85311D-5351-48F4-ABF0-4F5A4D9AEE0FQ41098508-0DA01213-9CFF-4CCA-A374-E85C37F35464Q42447530-D3EEF801-80D1-4AC6-A55E-7E89B7573DBF
P2860
Origins of breast cancer subtypes and therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Origins of breast cancer subtypes and therapeutic implications.
@en
type
label
Origins of breast cancer subtypes and therapeutic implications.
@en
prefLabel
Origins of breast cancer subtypes and therapeutic implications.
@en
P50
P356
P1476
Origins of breast cancer subtypes and therapeutic implications.
@en
P2860
P2888
P304
P356
10.1038/NCPONC0908
P577
2007-09-01T00:00:00Z
P5875
P6179
1003349942